 |
|
|
Item Details
| Title:
|
INHIBITORS OF CYCLIN-DEPENDENT KINASES AS ANTI-TUMOR AGENTS
|
| By: |
Paul J. Smith (Editor), Eddy W. Yue (Editor) |
| Format: |
Hardback |
| List price:
|
£205.00 |
| Our price: |
£184.50 |
| Discount: |
|
| You save:
|
£20.50 |
|
|
|
|
|
| ISBN 10: |
0849337747 |
| ISBN 13: |
9780849337741 |
| Availability: |
Reprinting. This item may be subject to delays or cancellation.
 Delivery
rates
|
| Stock: |
Currently 0 available |
| Publisher: |
TAYLOR & FRANCIS INC |
| Pub. date: |
1 October, 2006 |
| Series: |
Enzyme Inhibitors Series |
| Pages: |
448 |
| Description: |
Covering various aspects of cyclin-dependent kinases (CDKs), this volume examines CDKs as molecular and functional entities, their role in various disease processes, and their potential for pharmacological modulation. It explains the integration of cell cycle control pathways, opportunities for targeting, and targets of inhibitors. |
| Synopsis: |
One of the few books to cover all aspects of cyclin-dependent kinases (CDKs), Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents provides an overview of CDKs as molecular and functional entities, their involvement in different disease processes, and their potential for pharmacological modulation. With contributions from the top international researchers in the field, the book takes a contemporary approach to study the importance of rational drug design and knowledge-based therapeutics in relation to CDKs. The first two sections of the book discuss the integration of cell cycle control pathways, opportunities for targeting, targets of inhibitors, and the evaluation of CDK inhibitors, exploring topics such as the in vivo function of CDKs in normal homeostasisand tumor development and the structural biology of CDKs. The third section examines the design, development, and chemistry of small molecule CDK inhibitors, with discussions ranging from the early-stage discovery of new chemical entities with a capacity to inhibit CDKs to late-stage compounds in clinical development.The final section assesses the current status of CDK inhibitors in clinical trials, the therapeutic deployment challenges of small molecule inhibitors, and the future development of CDK inhibitors as anticancer agents. The field of drug development is at a critical point in terms of understanding the availability, advantages, and drawbacks of CDKs as therapeutic targets for small molecules. Providing the most up-to-date, in-depth coverage available in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues. |
| Illustrations: |
106 black & white illustrations, 8 colour illustrations, 76 black & white |
| Publication: |
US |
| Imprint: |
CRC Press Inc |
| Returns: |
Returnable |
|
|
|
 |
Ramadan and Eid al-Fitr
A celebratory, inclusive and educational exploration of Ramadan and Eid al-Fitr for both children that celebrate and children who want to understand and appreciate their peers who do.
|
|
|
|
|
|
|
|
|
|
|